ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #14,162Top JournalHybrid

Current Breast Cancer Reports

Acronym:cbcr
•
Identifier (ISSN):1943-4588(Print)/1943-4596(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCITop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Current Breast Cancer Reports

WoS Q4
01120.92023120240.9202512026
Annual Impact Factor Metric
Current (2026):1
Scopus SJR & RankScopus Q3
0.402
#14,162

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
28

28 papers with at least that number of citations each

WoS: ESCITop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
42articles/year
18.42% Gold OA•82.14% Original Research

Aims & Scope

This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of breast cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention, systemic therapy, and translational research. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Topics Covered (Recognized by AI)
MedicineInternal medicine99.6%Biology98.8%Genetics98.4%Cancer97.2%Breast cancer96.3%Oncology91.7%Surgery89.9%Surgical oncology85.8%Pathology54.6%Radiology34.5%Bioinformatics26.8%Chemistry26%Biochemistry24.3%Physics22.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ONCOLOGY

Q4
Rank302/333
IndexESCI
JCIESCI2026

ONCOLOGY

Q4
Rank304/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1
Articles / Year42
Total Citations7
2025
IF0.9
Articles / Year57
Total Citations51
2024
IF1
Articles / Year51
Total Citations117
2023
IF0.9
Articles / Year44
Total Citations156
2022
IF—
Articles / Year29
Total Citations115

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,162Scopus Q3SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.402

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,737 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations136
3-Year Documents121
Citable Documents120

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate70.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Breast Cancer Reports (acronym: cbcr, ISSN: 1943-4588) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer Nature in United States. The periodical holds a Journal Impact Factor (JIF) of 1.00, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.402 (Q3), an H-index of 28.

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues per year, an annual output of approximately 42 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,737 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
4 issues per year
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8b71a71f-5372-43ce-985b-52bce414d2b7
Database Updated: 2026-10-01